A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
Public ClinicalTrials.gov record NCT00081471. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-label Study of the Effect of Subcutaneous Mircera on Hemoglobin Level/Correction in Non-dialysis Patients With Chronic Kidney Disease
Study identification
- NCT ID
- NCT00081471
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Enrollment
- 324 participants
Conditions and interventions
Conditions
Interventions
- darbepoetin alfa Drug
- methoxy polyethylene glycol-epoetin beta [Mircera] Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2004
- Primary completion
- Jun 30, 2006
- Completion
- Jun 30, 2006
- Last update posted
- Nov 1, 2016
2004 – 2006
United States locations
- U.S. sites
- 22
- U.S. states
- 16
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Los Angeles | California | 90073 | — |
| Not listed | Mather | California | 95655 | — |
| Not listed | Stanford | California | 94305-5114 | — |
| Not listed | Stamford | Connecticut | 06902 | — |
| Not listed | Bay Pines | Florida | 33744 | — |
| Not listed | Ocala | Florida | 34471 | — |
| Not listed | Shreveport | Louisiana | 71101 | — |
| Not listed | Boston | Massachusetts | 02135 | — |
| Not listed | Boston | Massachusetts | 02215 | — |
| Not listed | Detroit | Michigan | 48236 | — |
| Not listed | Flushing | New York | 11355 | — |
| Not listed | Cincinnati | Ohio | 45220 | — |
| Not listed | Portland | Oregon | 97201-2940 | — |
| Not listed | Allentown | Pennsylvania | 18103 | — |
| Not listed | Columbia | South Carolina | 29209 | — |
| Not listed | Nashville | Tennessee | 37232 | — |
| Not listed | Austin | Texas | 78705 | — |
| Not listed | Dallas | Texas | 75216 | — |
| Not listed | Houston | Texas | 77054 | — |
| Not listed | Burlington | Vermont | 05401 | — |
| Not listed | Salem | Virginia | 24153 | — |
| Not listed | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 76 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00081471, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 1, 2016 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00081471 live on ClinicalTrials.gov.